Navigation Links
Ganeden Biotech Introduces the First Probiotic Thin Strip
Date:9/15/2009

CLEVELAND, Sept. 15 /PRNewswire/ -- Ganeden Biotech Inc., makers of the patented probiotic strain GanedenBC30(R), today announced the launch of the first quick dissolving, thin strip probiotic product. The new thin strip product is the latest in a number of innovative probiotic-enhanced products introduced by Ganeden Biotech over the past year.

The recent popularity of thin strips as a supplement delivery system led Ganeden Biotech to develop the new thin strip product as another option for consumers looking to improve their digestive and immune health with "good bacteria" or probiotics. The thin strip quickly adheres to the tongue making it an ideal delivery system for children, the elderly, individuals with trouble swallowing, and even some pets. In addition to the convenience of the thin strips, they provide an alternative for individuals who are unable or prefer not to take supplements in pill or liquid forms.

Available in a variety of flavors and dosages that have been formulated in applications for adults, children and companion animals, the new thin strips are shelf stable and deliver significant probiotic doses (up to 1.5 billion CFU/strip). The strips are available in convenient, turn-key 10 and 30 pack boxes of individually, foil packed strips that can be produced under private label for rapid market introduction.

Prior to the development of the Ganeden Biotech thin strip product, probiotic thin strip applications were limited as the harsh manufacturing conditions required to develop the strips would render most probiotic strains ineffective. However, the ability of GandenBC30 to survive these conditions, largely due to a naturally-occurring hardened shell of organic material that protects the bacteria, made it a viable probiotic for thin strip applications.

"We are thrilled to introduce this thin strip technology to the probiotic market," said Ganeden Biotech CEO Andrew Lefkowitz. "This innovative application is another step forward in expanding the breadth of convenient probiotic products available to consumers. We look forward to continuing to develop and bring to market new probiotic products that are core to Ganeden Biotech's mission to improve quality of life."

More information about the new thin strips and private label opportunities can be found at www.ganedenlabs.com.

About Ganeden Biotech

Founded in 1996, Ganeden Biotech Inc. is a private company based in Cleveland, Ohio, and is the largest seller of over-the-counter probiotics in the U.S. through its Digestive Advantage and Sustenex brands. It also licenses its patented probiotic bacteria, GanedenBC30, for use in commercial food and beverage applications as well as in medical foods and dietary supplements. GanedenBC30 was found to be Generally Recognized As Safe (GRAS) by an independent expert panel assembled to assess its safety in use as a food ingredient. Digestive Advantage and Sustenex are available at over 40,000 retailers nationwide including Walmart, CVS/pharmacy, Walgreens, Rite-Aid, Stop & Shop, Giant, Publix, Kroger, and Target. For more information, visit www.digestiveadvantage.com, www.sustenex.com, or www.ganedenlabs.com.


'/>"/>
SOURCE Ganeden Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Ganeden Biotech Obtains Self-Affirmed GRAS Status for Probiotic Ingredient, GanedenBC30 (Bacillus coagulans GBI-30, 6086)
2. Ganeden Biotech Takes Sustenex(TM) National with GanedenBC30 Probiotic
3. Isabellas Healthy Bakery Unveils Activate - A New Probiotic Muffin Fortified with GanedenBC30 Probiotic
4. Ganeden Biotech Receives Frost & Sullivan Probiotics Product Innovation Award
5. Ganeden Biotech and Heartland Sweeteners to Produce Probiotic Sweetener
6. Ganeden Biotech, Liquid Health Labs Unveil New Drink Technology
7. Ganeden Biotech Introduces GanPro(TM) Direct-Fed Microbial for Livestock
8. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
9. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
10. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
11. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... NEW YORK , Feb. 23, ... , a leading digital health company, and ... of telemedicine and remote patient monitoring, announce they ... reimbursements.  DN Telehealth maximizes collaboration ... real-time, extending consultations beyond a physical clinical setting ...
(Date:2/23/2017)... Atlanta, it seems everyone has a chance to express their ... expressive and dynamic community unlike any other. The businesses that ... With their newest salon in ... on that tradition with a unique, fresh approach to head ... the newest of 13 nationwide locations, each of them well-situated ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... during the 12th annual Inventors Recognition Reception at Purdue Research Park ... a faculty member in recognition of outstanding contributions to, and success with, commercializing ...
(Date:2/23/2017)... SAN FRANCISCO , Feb. 23, 2017   ... Beyond Type 1, a not-for-profit advocacy and education group ... a grant from Beyond Type 1 to support ViaCyte,s ... and other insulin-requiring diabetes.  For more ... cell-derived cell replacement therapies with a focus on the ...
Breaking Biology Technology:
(Date:2/13/2017)... Feb. 13, 2017  RSA Conference -- RSA, a ... is designed to enhance fraud detection and investigation ... the RSA Fraud & Risk Intelligence Suite. The ... leverage additional insights from internal and external sources ... protect their customers from targeted cybercrime attacks. ...
(Date:2/8/2017)... Feb. 7, 2017  Aware, Inc. (NASDAQ: AWRE ... reported financial results for its quarter and year ended December ... of 2016 was $3.9 million compared to $6.9 million in ... quarter of 2016 was $0.6 million compared to $2.6 million ... fourth quarter of 2016 was $0.5 million, or $0.02 per ...
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet ... in musculoskeletal healthcare, will present at the LEERINK Partners ... York Palace Hotel on Wednesday, February 15, 2017 at ... webcast of the presentation can be accessed at ... following the conference via Zimmer Biomet,s Investor Relations website ...
Breaking Biology News(10 mins):